Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction- the TRANSFER-AMI trial

Trial Profile

Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction- the TRANSFER-AMI trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2011

At a glance

  • Drugs Enoxaparin sodium; Heparin; Tenecteplase
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms TRANSFER-AMI
  • Most Recent Events

    • 03 Apr 2011 Results comparing outcomes after fibrinolysis with enoxaparin sodium versus heparin presented at the 60th Annual Scientific Session of the American College of Cardiology.
    • 15 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Feb 2009 New source identified and integrated (ISRCTN: Current Controlled Trials record).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top